Evaluation of Apelin-13 and Apelin-36 in Women With Recurrent Pregnancy Loss
NCT ID: NCT05205044
Last Updated: 2023-02-14
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
88 participants
OBSERVATIONAL
2022-01-23
2023-01-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
On Pregnancy After Losses - OPAL Study
NCT05167812
Longitudinal Study of the Clinical and Haematological Cause of Women With Antiphospholipid Antibodies.
NCT00180817
Aspirin, Heparin and Miscarriage
NCT01917799
Low Dose Prednisone Therapy in Women With Recurrent Pregnancy Loss
NCT04558268
Preconceptional Thromboprophylaxis in Recurrent PREGNANCY LOSSES Caused by Antiphospholipid Syndrome
NCT01661439
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_CONTROL
CROSS_SECTIONAL
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Recurrent pregnancy loss
Apelin-13, Apelin-36
Serum levels of Apelin-13 and Apelin-36
Healthy
Apelin-13, Apelin-36
Serum levels of Apelin-13 and Apelin-36
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Apelin-13, Apelin-36
Serum levels of Apelin-13 and Apelin-36
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* negative antiphospholipid markers
* normal karyotype
Exclusion Criteria
* fetal malformations
* maternal diseases
* smoking or alcohol use
* history of or risk factors for preterm labor
18 Years
40 Years
FEMALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Ain Shams University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Ain Shams University Maternity Hospital
Cairo, Cairo/القاهرة, Egypt
AinShams Maternity Hospital
Cairo, , Egypt
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
MS 672/2021
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.